PKA Antikörper (Catalytic Subunit)

Produktnummer ABIN7075244

Dieses Kaninchen Polyklonal-Antikörper erkennt spezifisch PKA in WB. Er zeigt eine Reaktivität gegenüber Human, Maus und Ratte.

Kurzübersicht für PKA Antikörper (Catalytic Subunit) (ABIN7075244)

Target: PKA (Protein Kinase A (PKA))

Reaktivität: Human, Maus, Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PKA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-PKA Antikörper

Bindungsspezifität: Catalytic Subunit

Kreuzreaktivität: Human, Ratte

Aufreinigung: Affinity purification

Immunogen: Recombinant protein corresponding to Mouse PKA alpha+beta

Anwendungsinformationen

Applikationshinweise: WB (H,M,R) 1: 500-1: 1000

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: PBS, pH 7.4, 0.02 % sodium azide

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C

Details zu PKA

Target: PKA (Protein Kinase A (PKA))

Andere Bezeichnung: PKA alpha+beta

Hintergrund: The catalytic subunit α of protein kinase A is a key regulatory enzyme that in humans is encoded by the PRKACA gene. This enzyme is responsible for phosphorylating other proteins and substrates, changing their activity. Protein kinase A catalytic subunit (PKA Cα) is a member of the AGC kinase family (protein kinases A, G, and C), and contributes to the control of cellular processes that include glucose metabolism, cell division, and contextual memory. PKA Cα is part of a larger protein complex that is responsible for controlling when and where proteins are phosphorylated. Defective regulation of PKA holoenzyme activity has been linked to the progression of cardiovascular disease, certain endocrine disorders and cancers.

Molekulargewicht: 41 kDa

Gen-ID: 18747

NCBI Accession: NP_001264827

UniProt: P05132

Pathways: SARS-CoV-2 Protein Interaktom